Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
My message (sent for attn of S Andersen) rather than addressed to Walbrook
"Dear Mr Andersen,
I know I am not alone among shareholders in thinking that communication with us, since PBX went alone, has been lacking.
I understood from Walbrook that you were going to set out plans for 2024. We are almost half way through the year, and still nothing.
In the half year figures, orders received though not all booked, had exceeded revenues for all of 2022. Please could you provide a trading update.
Finally, I would love to add to my shareholding, but am loath to do so whilst on Aquis. Please get a listing on PBX. [edit my error, but I think they know I mean AIM]
Many thanks
Martin U"
And Walbrook's response
"Thank you for your email. We had planned to do an update before now, but various external factors prevented this unfortunately. Your comments are noted and I will pass them on to Steen. We will certainly be doing an update at the results."
Such a simple thing to do and file before overdue
https://find-and-update.company-information.service.gov.uk/company/11330264
anybody at home?
mol
mol
1.5m in orders in the first 6 months. We have no way to know if they were all delivered and invoiced in 2023.
They have to announce results by the end of June so not long to wait now.
Yes, i missed this. Thanks.
This is a longer extract from H1 2023.
"During the first half of the financial year the Group received confirmed orders totalling £1.5m which is 16% greater than turnover for the period to 31 December 2022 of £1.31m. Of the orders received, £552k (2021: £302k) had been completed and invoiced as at 30 June 2023. The increase in sales for the first half of the year reflects strong development in new customer acquisition as well as growth from existing customers. Gross profit for the period amounted to £264k (2022: £154k)."
A lot depends on how much of orders are actually booked. And indeed, paid for in reasonable time.
C 5hours ago from the under noted
ProBiotix Health
407 followers
5h
Did you spot us in the latest edition of Nutramedic & Cosmetics in its Vitafoods Europe 2024 preview? Our innovative InstaMelt formulation is launching at the exhibition.
Visit us at stand P56 to learn more, or discover why it's great for cardiometabolic health
yes i did - lol
it's where i got the blurb as posted
https://nmc-magazine.com/vitafoods-europe-2024-preview/
mol
C 3 weeks ago
Steen Dannemann Andersen
Chief Executive Officer & Board member
3w
Dear network
Is there ANY chance that you might know someone, dynamic, driven by “hunting” and all aspects of hands-on sales and customer interaction? Someone who has 3-5 years under the belt and is ready for his or her next professional sales challenge. If you do, please, please put me in contact with that person.
I have a sales job proposal which is hard to resist, in an exceptional organization full of ambitions, entrepreneurship, team spirit and room for shaping own workday to create a healthy work/life balance.
We are committed to support healthy living under the motto “it is not about adding years to life but adding life to years”. Our dedication has led to exceptionally fast growth of the company. Our value proposition is to offer consumers clinically documented natural probiotic supplements supporting maintenance of healthy cholesterol and blood pressure levels throughout life. Our dietary supplement products are brought to market by leading regional and global companies under their own brand.
Our mission is real as almost 20 million people die from cardiovascular diseases every year of which 4 million are directly linked to elevated cholesterol levels. If our products by any means could just fractionally support lowering that numbers our mission is accomplished.
We are expanding rapidly out of our headquarters in Denmark, and the ideal profile would be someone willing to work from HQ as basis, but as the role covers sales in all of Europe, he or she also could be based in another Scandinavian or European country.
hmm...
obviously otherwise engaged martinu to provide the update noted in your approach to Walbrook
anyway 30 June 2024 rapidly approaching re 31 Dec 2023 audited financial statements due
mol
Sales up to the end of June 2023 for H1 were 550k. I don't understand where the 750k comes from?
I looking forward to full year figures for 2023, SOH has mentioned back in April 23 that they had done sales of £750k in first 4 months of 2023 and projected sales of £2.5m for year end - being very profitable.
This stock seems to get forgotten about being on this exchange but I think people will hopefully take more notice after results.
Instamelt? Awkward: https://www.conservingbeauty.com/collections/for-cleansing/products/instamelt%E2%84%A2-day-dissolver-wipes-30-pack
And
https://probiotixhealth.com/probiotix-health-launches-new-innovative-instamelt-formulation-to-support-cardiometabolic-health-at-vitafoods-europe/
https://probiotixhealth.com/healthy-ageing-longevity-and-metabolic-health-a-key-focus-at-vitafoods-europe-2024/
mol
And rebranded to yourbiotix (albeit the old cholbiome still has a presence on clicking a number of the links and of course still on opti online as same)
https://probiotixhealth.com/
https://probiotixhealth.com/products/
mol
Booth: P56
ProBiotix Health launches new innovative InstaMelt formulation to support cardiometabolic health.
ProBiotix Health Plc (‘ProBiotix’), a life sciences company that develops finished probiotic formulations to support cardiometabolic health, has launched InstaMelt – a newly developed food supplement that offers innovative features for health brands and retailers to rebrand as a full turn-key solution.
Featuring two science-backed and natural ingredients, the InstaMelt formulation contains the company’s proprietary ingredient LPLDL®, a patented probiotic strain with proven efficacy from multiple independent human intervention studies to significantly decrease LDL and increase HDL cholesterol levels, and Thiamine (Vitamin B1), which supports heart function.
ProBiotix has a keen interest in healthy ageing solutions that not only add years to life but add life to years. With global life expectancy rising, health spans must also rise to meet that expectation.
Niels Peter Bak, Head of Product Management at ProBiotix, commented: “Our InstaMelt formulation uses InstaMelt technology, a unique dosing technology to help health brands deliver the patented strain in a novel and convenient way. Its superior organoleptic properties, combined with natural fruit flavours, make the InstaMelt formulation a great addition to any heart health and wellness portfolio.”
Available in redberry and peach flavours, visitors will be able to taste InstaMelt at stand P56, alongside viewing the company’s full product range.
mol
A further US patent granted 20 February 2024
https://patents.justia.com/patent/11903979#history
albeit doesn't at moment seem to have been assigned to pbx though i'm no expert in these matters and it is not the first according to list below
https://patents.justia.com/inventor/stephen-patrick-o-hara
mol
Has there been any update of how well the company did in 2023 and what the outlook is for 2024 as well any update on new product development etc.
The last real RNS with that type of info was on "27 Sep 2023 - Half-year Report" which covered to 30 June 2023. I'd have thought the full year report would have been released by now.
My wife has been smoking for over 50 years and also hasn't had any side effects yet but not sure that should reassure anyone about the impact of cigarettes. The bottom line is that as LPLDL is clinically proven to lower cholesterol on its own, why persevere with a product containing red yeast at levels considered unsafe by other jurisdictions?
"Q. My bad cholesterol has been rising, and my doctor suggested that I start taking a statin. I've read that red yeast rice has many of the cholesterol-lowering benefits of a statin, and I would rather go the natural route. However, I recently heard on a newscast that red yeast rice can have adverse effects on the kidneys. Is it still safe for me to take this supplement?
A. It's true that red yeast rice, which contains monacolin K, a chemical that's identical to the active ingredient in the cholesterol-lowering drug lovastatin (Mevacor), may reduce your LDL (bad) cholesterol and lower your total cholesterol. However, an independent analysis of a dozen 600-milligram (mg) capsules of red yeast rice products conducted a few years ago found that the actual monacolin K content varied widely — from 0.1 mg to 10.9 mg. (The lowest dose of lovastatin is 20 mg.) In addition, one-third of the products were contaminated with a potentially toxic compound called citrinin, which can damage the kidneys. The Food and Drug Administration (FDA) has blocked the sale of red yeast rice supplements that contain enough of the active ingredient to make them as effective as lovastatin because they haven't undergone the drug approval process. Unlike FDA-approved drugs, supplements can be sold without proof of effectiveness and purity."
https://www.health.harvard.edu/cholesterol/can-i-use-red-yeast-rice-instead-of-a-statin-to-lower-my-cholesterol
I've been using x3 for 1 year now....great product and very effective.
no side effects or issues with it what so ever!
Typical. I bought a box of that the other day
Already banned in US and heavily restricted in the EU, issues now raised in Japan. Amazed PBX still sells Cholbiome X3 in the UK
https://www.bbc.co.uk/news/world-asia-68662585
Today, I sent yet another follow up to this exchange with Walbrook from early Dec.
"Apologies for the delay. I was on holiday when you sent the original email and it fell under my radar after I got back. The Company is working constantly on delivering milestones and increasing liquidity. The latter is difficult in these markets, but they have a defined strategy in place. For your information, we intend to hold an investor presentation (hosted on the IMC platform) in the New Year where Steen will lay out the plans for 2024 and how he and the Board plan to delivery growth."
Got a prompt reply!
"We will be holding an IMC for PBX. And we will let the market know... as soon as we have a date!"
Thanks for putting me straight on this. It is the same company as referred to in half year report.
Thanks BK, translation of the page below
"Dual-Level Support: SymbioLife® Cholesterol Control* provides support to our body on two levels, naturally normalizing cholesterol levels.
It contains the bacterium Lactobacillus plantarum LPLDL®, harnessing the significant impact of natural bacteria on our health. Intestinal bacteria, particularly of the Lactobacillus genus, can regulate our cholesterol levels by binding to cholesterol or incorporating it into their own cell membranes.
The specific intestinal bacterium Lactobacillus plantarum LPLDL® also increases our excretion of bile acids. As a result, our body produces more bile acids, which are essential for fat digestion, and in turn, removes cholesterol from the blood.
In addition to this, SymbioLife® Cholesterol Control contains phytosterols*, secondary plant compounds that possess a structure similar to cholesterol. When we consume phytosterols, our intestinal wall transports them into our body instead of cholesterol.
The remaining cholesterol in the intestine is then excreted with the stool, leading to a decrease in cholesterol levels"